JP2019508044A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508044A5 JP2019508044A5 JP2018546653A JP2018546653A JP2019508044A5 JP 2019508044 A5 JP2019508044 A5 JP 2019508044A5 JP 2018546653 A JP2018546653 A JP 2018546653A JP 2018546653 A JP2018546653 A JP 2018546653A JP 2019508044 A5 JP2019508044 A5 JP 2019508044A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- recombinant nucleic
- acid vector
- sequence
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662310551P | 2016-03-18 | 2016-03-18 | |
| US62/310,551 | 2016-03-18 | ||
| US201662313596P | 2016-03-25 | 2016-03-25 | |
| US62/313,596 | 2016-03-25 | ||
| PCT/US2017/023117 WO2017161360A2 (en) | 2016-03-18 | 2017-03-20 | Multimodal vector for dendritic cell infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019508044A JP2019508044A (ja) | 2019-03-28 |
| JP2019508044A5 true JP2019508044A5 (enExample) | 2020-04-16 |
Family
ID=59850551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018546653A Pending JP2019508044A (ja) | 2016-03-18 | 2017-03-20 | 樹状細胞感染のための多モードベクター |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210198689A1 (enExample) |
| EP (1) | EP3430148A4 (enExample) |
| JP (1) | JP2019508044A (enExample) |
| KR (1) | KR20180118198A (enExample) |
| CN (1) | CN109312364A (enExample) |
| AU (1) | AU2017233072B2 (enExample) |
| CA (1) | CA3016389A1 (enExample) |
| IL (1) | IL261812A (enExample) |
| MX (1) | MX2018011306A (enExample) |
| SG (1) | SG11201808058PA (enExample) |
| WO (1) | WO2017161360A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201414021D0 (en) | 2014-08-07 | 2014-09-24 | Nascient Ltd | Biological materials and uses thereof |
| DK3288573T3 (da) | 2015-04-30 | 2020-03-16 | Psioxus Therapeutics Ltd | Onkolytisk adenovirus, der koder for et b7-protein |
| AU2016311444B2 (en) | 2015-08-25 | 2019-02-07 | Nantomics, Llc | Systems and methods for high-accuracy variant calling |
| US11155622B2 (en) | 2015-12-17 | 2021-10-26 | Psioxus Therapeutics Limited | Virus encoding an anti-TCR-complex antibody or fragment |
| KR20210010678A (ko) | 2016-06-30 | 2021-01-27 | 난트 홀딩스 아이피, 엘엘씨 | 난트 암 백신 |
| US12653874B2 (en) | 2016-06-30 | 2026-06-16 | Immunitybio, Inc. | Nant cancer vaccine |
| KR102491752B1 (ko) | 2016-08-29 | 2023-01-26 | 싸이오서스 테라퓨틱스 엘티디. | 이중특이성 T 세포 세포 관여자(BiTE)가 보강된 아데노바이러스 |
| GB201713765D0 (en) | 2017-08-28 | 2017-10-11 | Psioxus Therapeutics Ltd | Modified adenovirus |
| AU2018277294B2 (en) | 2017-06-01 | 2025-04-24 | Akamis Bio Limited | Oncolytic virus and method |
| GB201801614D0 (en) | 2018-01-31 | 2018-03-14 | Psioxus Therapeutics Ltd | Formulation |
| US11823773B2 (en) | 2018-04-13 | 2023-11-21 | Nant Holdings Ip, Llc | Nant cancer vaccine strategies |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU774076C (en) * | 1998-12-09 | 2005-04-14 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| ES2404689T3 (es) * | 2001-04-05 | 2013-05-28 | The Johns Hopkins University | Vacunas quiméricas que comprenden el dominio lumenal de LAMP-1 o LAMP-2 |
| EP1441758A2 (de) * | 2001-11-09 | 2004-08-04 | MediGene Aktiengesellschaft | Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle |
| WO2005035773A2 (en) * | 2003-10-08 | 2005-04-21 | Sanofi Pasteur, Inc. | Modified cea /b7 vector |
| CN1761757A (zh) * | 2003-01-07 | 2006-04-19 | 香港大学 | 用血管抑制素协同加强腺伴随病毒介导的b7.1免疫接种以根除扩散的肝转移性肿瘤 |
| WO2006108241A1 (en) * | 2005-04-14 | 2006-10-19 | The University Of Queensland | Immunomodulating compositions and uses therefor |
| RU2013118723A (ru) * | 2010-09-24 | 2014-10-27 | Онкос Терапьютикс Ой | Онколитические аденовирусные векторы, кодирующие моноклональные антитела против ctla-4 |
| DK2751279T3 (da) * | 2011-08-31 | 2017-11-20 | St Jude Children's Res Hospital | Fremgangsmåder og sammensætninger til påvisning af niveauet af lysosomal exocytose-aktivitet og fremgangsmåder til anvendelse |
| CN102533859A (zh) * | 2012-01-12 | 2012-07-04 | 中国人民解放军第二军医大学 | 携带可诱导性共刺激分子基因的腺病毒载体及其构建方法与应用 |
| JP6430949B2 (ja) * | 2012-10-23 | 2018-11-28 | エモリー ユニバーシティ | Ｇｍ−ｃｓｆとｉｌ−４のコンジュゲート、組成物、ならびにそれに関連する方法 |
| EP3524262A1 (en) * | 2013-11-01 | 2019-08-14 | Pfizer Inc | Vectors for expression of prostate-associated antigens |
| JP6535337B2 (ja) * | 2013-11-05 | 2019-06-26 | バヴァリアン・ノルディック・アクティーゼルスカブ | 腫瘍抗原を発現するポックスウイルスならびに免疫チェックポイント阻害剤のアンタゴニスト及び／またはアゴニストにより癌を治療するための組み合わせ療法 |
| JP7060324B2 (ja) * | 2013-12-20 | 2022-04-26 | ザ・ブロード・インスティテュート・インコーポレイテッド | ネオ抗原ワクチンによる併用療法 |
| EP3097117B1 (en) * | 2014-01-21 | 2023-10-04 | Novartis Ag | Enhanced antigen presenting ability of car t cells by co-introduction of costimulatory molecules |
| GB201406608D0 (en) * | 2014-04-12 | 2014-05-28 | Psioxus Therapeutics Ltd | Virus |
| DK3142690T3 (da) * | 2014-05-13 | 2022-05-09 | Bavarian Nordic As | Kombinationsterapi til behandling af cancer med et rekombinant poxvirus, der eksprimerer et tumorantigen, og en immun-checkpointmolekyleantagonist eller -agonist |
-
2017
- 2017-03-20 AU AU2017233072A patent/AU2017233072B2/en not_active Ceased
- 2017-03-20 EP EP17767693.9A patent/EP3430148A4/en not_active Withdrawn
- 2017-03-20 US US16/081,014 patent/US20210198689A1/en not_active Abandoned
- 2017-03-20 MX MX2018011306A patent/MX2018011306A/es unknown
- 2017-03-20 CN CN201780017523.9A patent/CN109312364A/zh active Pending
- 2017-03-20 CA CA3016389A patent/CA3016389A1/en not_active Abandoned
- 2017-03-20 KR KR1020187028404A patent/KR20180118198A/ko not_active Ceased
- 2017-03-20 WO PCT/US2017/023117 patent/WO2017161360A2/en not_active Ceased
- 2017-03-20 JP JP2018546653A patent/JP2019508044A/ja active Pending
- 2017-03-20 SG SG11201808058PA patent/SG11201808058PA/en unknown
-
2018
- 2018-09-16 IL IL261812A patent/IL261812A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xiao et al. | CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy | |
| Cui et al. | Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer | |
| JP2019176869A5 (enExample) | ||
| ES3049406T3 (en) | Methods for profiling the t-cell-receptor repertoire | |
| De Haan et al. | Viral gene delivery vectors: the next generation medicines for immune-related diseases | |
| US20180000912A1 (en) | Virus Vectors Expressing Multiple Epitopes of Tumor Associated Antigens For Inducing Antitumor Immunity | |
| JP2018508567A5 (enExample) | ||
| JP2019524773A (ja) | 樹状細胞のトランスフェクション及びその方法 | |
| WO2017161360A4 (en) | Multimodal vector for dendritic cell infection | |
| JP2014523406A5 (enExample) | ||
| JP2017538401A5 (enExample) | ||
| JP2017525336A5 (enExample) | ||
| Lin et al. | Boosting with recombinant vaccinia increases HPV-16 E7-Specific T cell precursor frequencies and antitumor effects of HPV-16 E7-expressing Sindbis virus replicon particles | |
| Goyal et al. | Advancing cancer immunotherapy: the potential of mRNA vaccines as a promising therapeutic approach | |
| Shariati et al. | mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy | |
| CN112154204A (zh) | 基因工程化的细胞及应用 | |
| CN110859968A (zh) | 激活对肿瘤的系统免疫反应的基因生物药物 | |
| Odegard et al. | Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy | |
| Xu et al. | Current status of antigen-specific T-cell immunotherapy for advanced renal-cell carcinoma | |
| JP2023017853A (ja) | 新規な癌抗原及び方法 | |
| JP2023522198A (ja) | 黒色腫を治療するためのｃｔｌ抗原の融合タンパク質 | |
| Crowley et al. | Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH | |
| JP2015524788A5 (enExample) | ||
| Bellone et al. | Advances in dendritic cell-based therapeutic vaccines for cervical cancer | |
| CN110234358A (zh) | 多病毒特异性的t细胞免疫疗法 |